Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae

Biochemistry and Cell Biology

Volumn 80, Issue 5, 2002, Pages 639-644

  Vickers, Mark F ^a   Kumar, Rakesh ^a   Visser, Frank ^a   Zhang, Jing ^a   Charania, Jahangir ^a   Raborn, R Taylor ^a   Baldwin, Stephen A ^b   Young, James D ^a   Cass, Carol E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

araC; hENT1; hENT2; NBMPR; Uridine

Indexed keywords

AMINO ACIDS;

CYTIDINE; URIDINE;

CELL CULTURE;

2',3' DIDEOXYURIDINE; 3' AZIDO 2' DEOXYURIDINE; 3' DEOXYCYTIDINE; 5 METHOXYURIDINE; 5 METHYL 2' DEOXY 3' AZIDOURIDINE; 5 METHYLURIDINE; BASE; BROXURIDINE; CYTIDINE; CYTIDINE DERIVATIVE; DEOXYCYTIDINE; DEOXYURIDINE; DOXIFLURIDINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; FLOXURIDINE; FLUOROURIDINE; HALOGEN; HYDROXYL GROUP; IODOURIDINE; MEMBRANE PROTEIN; PYRIMIDINE NUCLEOSIDE DERIVATIVE; RECOMBINANT PROTEIN; RIBOSE; TRITIUM; UNCLASSIFIED DRUG; URIDINE; URIDINE DERIVATIVE; ZALCITABINE;

ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; GENE EXPRESSION SYSTEM; INHIBITION KINETICS; MEMBRANE TRANSPORT; NONHUMAN; NUCLEOSIDE TRANSPORT; PROTEIN INTERACTION; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; YEAST;

BIOLOGICAL TRANSPORT; CYTIDINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2; HUMANS; PYRIMIDINE NUCLEOSIDES; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; URIDINE;

SACCHAROMYCES CEREVISIAE; TRITIUM;

EID: 0347997273     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o02-148     Document Type: Article

References (30)

1. Brunelli, J.P., and Pall, M.L. 1993. A series of yeast shuttle vectors for expression of cDNAs and other DNA sequences. Yeast, 9: 1299-1308.
2. Cass, C.E., and Paterson, A.R. 1972. Mediated transport of nucleosides in human erythrocytes. Accelerative exchange diffusion of uridine and thymidine and specificity toward pyrimidine nucleosides as permeants. J. Biol. Chem. 247: 3314-3320.
3. Cass, C.E., and Paterson, A.R. 1973. Mediated transport of nucleosides by human erythrocytes. Specificity toward purine nucleosides as permeants. Biochim. Biophys. Acta, 291: 734-746.
4. Cass, C.E., Young, J.D., and Baldwin, S.A. 1998. Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem. Cell Biol. 76: 761-770.
5. Cass, C.E., Young, J.D., Baldwin, S.A., Cabrita, M.A., Graham, K.A., Griffiths, M., Jennings, L.L., Mackey, J.R., Ng, A.M.L., Ritzel, M.W.L., Vickers, M.F., and Yao, S.Y.M. 1999. Nucleoside transporters of mammalian cells. Membrane transporters as drug targets. Vol. 12. Edited by G.L. Amidon and W. Sadee. Kluwer Academic/Plenum Publishers, Norwell, Mass.
6. Crawford, C.R., Patel, D.H., Naeve, C., and Belt, J.A. 1998. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J. Biol. Chem. 273: 5288-5293.
7. Griffith, D.A., and Jarvis, S.M. 1996. Nucleoside and nucleobase transport systems of mammalian cells. Biochim. Biophys. Acta, 1286: 153-181.
8. Griffiths, M., Beaumont, N., Yao, S.Y., Sundaram, M., Boumah, C.E., Davies, A., Kwong, F.Y., Coe, I., Cass, C.E., Young, J.D., and Baldwin, S.A. 1997a. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat. Med. 3: 89-93.
9. Griffiths, M., Yao, S.Y., Abidi, F., Phillips, S.E., Cass, C.E., Young, J.D., and Baldwin, S.A. 1997b. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem. J. 328(Pt. 3): 739-743.
10. Horwitz, J.P., Chua, J., and Noel, M. 1964. The monomesylates of 1-(2′-deoxy-β-D-lixofuranosyl)thymine. J. Org. Chem. 29: 2076-2078.
11. Ito, H., Fukuda, Y., Murata, K., and Kimura, A. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153: 163-168.
12. 3H]nitrobenzylthioinosine-labelled nucleoside transporter in human erythrocytes. Biochem. J. 230: 777-784.
13. Jarvis, S.M. 1986. Trans-stimulation and trans-inhibition of uridine efflux from human erythrocytes by permeant nucleosides. Biochem. J. 233: 295-297.
14. Jennings, L.L., Hao, C., Cabrita, M.A., Vickers, M.F., Baldwin, S.A., Young, J.D., and Cass, C.E. 2001. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology, 40: 722-731.
15. Kumar, R., Wiebe, L.I., and Knaus, E.E. 1994. A mild and efficient methodology for the synthesis of 5-halogenouracil nucleosides that occurs via a 5-halogeno-6-azido-5,6-dihydro intermediate. Can. J. Chem. 72: 2005-2010.
16. Kumar, R., Wang, L., Wiebe, L.I., and Knaus, E.E. 1996. Synthesis, in vitro biological stability, and anti-HIV activity of 5-halo(or methoxy)-6-alkoxy(azido or hydroxy)-5,6-dihydro-2′,3′-didehydro-3′-deoxythymidine diastereomers as potential prodrugs of 2′,3′-didehydro-3′-deoxythmidine. Nucleosides Nucleotides, 15: 265-286.
17. Mackey, J.R., Baldwin, S.A., Young, J.D., and Cass, C.E. 1998. Nucleoside transport and its significance for anticancer drug resistance. Drug Resist. Updates, 1: 310-324.
18. Mackey, J.R., Yao, S.Y., Smith, K.M., Karpinski, E., Baldwin, S.A., Cass, C.E., and Young, J.D. 1999. Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. J. Natl. Cancer Inst. 91: 1876-1881.
19. Pennycooke, M., Chaudary, N., Shuralyova, I., Zhang, Y., and Coe, I.R. 2001. Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem. Biophys. Res. Commun. 280: 951-959.
20. SenGupta, D.J., Lum, P.Y., Lai, Y., Shubochkina, E., Bakken, A.H., Schneider, G., and Unadkat, J.D. 2002. A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine. Biochemistry, 41: 1512-1519.
21. Sundaram, M., Yao, S.Y., Ingram, J.C., Berry, Z.A., Abidi, F., Cass, C.E., Baldwin, S.A., and Young, J.D. 2001. Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs. J. Biol. Chem. 276: 45 270 - 45 275.
22. Tse, C.M., Belt, J.A., Jarvis, S.M., Paterson, A.R., Wu, J.S., and Young, J.D. 1985. Reconstitution studies of the human erythrocyte nucleoside transporter. J. Biol. Chem. 260: 3506-3511.
23. Vickers, M.F., Mani, R.S., Sundaram, M., Hogue, D.L., Young, J.D., Baldwin, S.A., and Cass, C.E. 1999. Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q). Biochem. J. 339(Pt. 1): 21-32.
24. Vickers, M.F., Yao, S.Y., Baldwin, S.A., Young, J.D., and Cass C.E. 2000a. Nucleoside transporter proteins of Saccharomyces cerevisiae. Demonstration of a transporter (FUI1) with high uridine selectivity in plasma membranes and a transporter (FUN26) with broad nucleoside selectivity in intracellular membranes. J. Biol. Chem. 275: 25 931 - 25 938.
25. Vickers, M.F., Young, J.D., Baldwin, S.A., Mackey, J.R., and Cass, C.E. 2000b. Nucleoside transporter proteins: emerging targets for drug discovery. Emerging Ther. Targets, 4: 515-539.
26. Vickers, M.F., Young, J.D., Baldwin, S.A., Ellison, M.J., and Cass, C.E. 2001. Functional production of mammalian concentrative nucleoside transporters in Saccharomyces cerevisiae. Mol. Membr. Biol. 18: 73-79.
27. Visser, F., Vickers, M.F., Ng, A.M., Baldwin, S.A., Young, J.D., and Cass, C.E. 2002. Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole. J. Biol. Chem. 277: 395-401.
28. Ward, J.L., Sherali, A., Mo, Z.P., and Tse, C.M. 2000. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J. Biol. Chem. 275: 8375-8381.
29. Yao, S.Y., Ng, A.M., Vickers, M.F., Sundaram, M., Cass, C.E., Baldwin, S.A., and Young, J.D. 2002. Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ent2 helix 5-6 region in nucleobase translocation. J. Biol. Chem. 277: 24 938 - 24 948.
30. Zimmerman, T.P., Mahony, W.B., and Prus, K.L. 1987. 3′-Azido-3′-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion. J. Biol. Chem. 262: 5748-5754.